Three Seasons Wealth, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Three Seasons Wealth, LLC
- $202 Billion
- Q1 2025
A detailed history of Three Seasons Wealth, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Three Seasons Wealth, LLC holds 20,324 shares of CPRX stock, worth $493,873. This represents 0.24% of its overall portfolio holdings.
Number of Shares
20,324Holding current value
$493,873% of portfolio
0.24%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
364Shares Held
95.5MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$454 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$206 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$141 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$76.2 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$76.1 Million1.62% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.5B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...